279 related articles for article (PubMed ID: 6790449)
1. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
Urien S; Albengres E; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
Cramer JA; Mattson RH
Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
[TBL] [Abstract][Full Text] [Related]
3. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
Brunner F; Zini R; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
[TBL] [Abstract][Full Text] [Related]
4. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
Albengres E; Urien S; Kusmierek J; Tillement JP
Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
[TBL] [Abstract][Full Text] [Related]
5. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
6. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
Riva R; Albani F; Contin M; Baruzzi A; Altomare M; Merlini GP; Perucca E
Ther Drug Monit; 1984; 6(1):25-30. PubMed ID: 6424276
[TBL] [Abstract][Full Text] [Related]
8. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
Font G; Mañes J; Martre H; Prognon P; Mahuzier G
Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
10. Disposition and protein binding of valproic acid in the developing rat.
Haberer LJ; Pollack GM
Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting serum protein binding of cocaine in humans.
Parker RB; Williams CL; Laizure SC; Lima JJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
[TBL] [Abstract][Full Text] [Related]
12. Can the serum protein binding of valproic acid limit the hepatic elimination?
Kodama Y; Kuranari M; Teraoka I; Fujii I; Takeyama M
Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):529-32. PubMed ID: 8294164
[TBL] [Abstract][Full Text] [Related]
13. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
Wosilait WD; Ryan MP; Byington KH
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
[TBL] [Abstract][Full Text] [Related]
14. Blood binding of selezen (imidazole salicylate) in man.
Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
[TBL] [Abstract][Full Text] [Related]
15. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
Ozer I; Tacal O
Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.
Gugler R; Mueller G
Br J Clin Pharmacol; 1978 May; 5(5):441-6. PubMed ID: 350249
[TBL] [Abstract][Full Text] [Related]
17. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
[TBL] [Abstract][Full Text] [Related]
18. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
Semmes RL; Shen DD
Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
[TBL] [Abstract][Full Text] [Related]
19. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
20. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
Storck J; Kirsten R
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
